Previous Article | Next Article ![]()
Journal of Bacteriology, September 2004, p. 5899-5905, Vol. 186, No. 17
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.17.5899-5905.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Takatsugu Kobayashi,1 James R. Walker,4 and Shigeyuki Yokoyama1,2,5*
Department of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo,1 RIKEN Genomic Sciences Center, Tsurumi, Yokohama,2 Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto,3 RIKEN Harima Institute at SPring-8, 1-1-1 Kohto, Sayo, Hyogo, Japan,5 Section of Molecular Genetics and Microbiology and Institute for Cellular and Molecular Biology, University of Texas, Austin, Texas4
Received 13 February 2004/ Accepted 21 May 2004
|
|
|---|
|
|
|---|
The E. coli argU10(Ts) mutation in the argU gene inhibits DNA replication, which stops cell growth at a high temperature (12), and causes the Pin phenotype at a permissive temperature (2). The argU10(Ts) defects were suggested to be due to impaired translation of the AGA and AGG codons in the mutant cells, for two reasons. First, the argU10(Ts) mutation is a G-to-A transition at the 5' end of the argU tRNA, which generates a mismatched base pair at the terminus of the acceptor stem (2) (Fig. 1); this structural alteration may impair the tRNA function. Second, some replication genes contain a few AGA or AGG codons, while the old gene from bacteriophage P2, involved in the Pin phenotype, contains eight AGA or AGG codons (10). A reporter gene containing AGA and AGG codons can hardly be expressed in the argU10(Ts) mutant cells at a high temperature, and moderate inhibition of AGA and AGG translation was observed at the permissive temperature (2). These different levels of AGA and AGG translation inhibition explain the various phenotypes caused by the argU10(Ts) mutation. On the other hand, the molecular mechanism by which the argU10(Ts) mutation impairs AGA and AGG translation has remained obscure.
![]() View larger version (17K): [in a new window] |
FIG. 1. Secondary structure of the argU tRNA. The argU10(Ts) mutation, a G-to-A transition at position 1, is indicated. The modified nucleotides found in this tRNA are dihydrouridine (D), 2-thiocytidine (s2C), 5-methylaminomethyluridine (mnn5U), N6-threonine carbamoyl adenosine (t6A), pseudouridine ( ), and 5-methyluridine (T) (17, 33).
|
|
|
|---|
Recombinant DNA technology, DNA sequencing, and PCR.
Standard techniques were used for isolation of plasmid or
phage DNA, restriction endonuclease digestion, ligation, and gel electrophoresis (35). E. coli cells were transformed by using a Gene Pulser electroporation apparatus (Bio-Rad Laboratories). PCR was performed by using AmpliTaq (Takara Shuzo, Kyoto, Japan) and a DNA PJ480 thermal cycler (Perkin-Elmer Cetus). Nucleotide sequencing was performed by the dideoxy chain termination method (36) by using an AmpliTaq sequencing kit (Takara Shuzo).
Plasmids carrying the argU alleles and the argS gene.
Plasmid pDM1, carrying the wild-type argU gene, has been described previously (25), while the 4.5-kb argU10(Ts) HindIII chromosomal fragment (2) was cloned into the vector pBR322 to generate pKC1. Plasmid pAp102 was created by ligating the gene encoding ß-lactamase to the 2-kb EcoRI-XbaI fragment containing the sequence essential for autonomous replication of ColIb-P9 (11). The NaeI-VspI fragment of pUC119, which includes the gene encoding the
-fragment of lacZ together with the multiple cloning site in it, was cloned into the EcoRI site of pAp102 to generate pCL1. Plasmid pCL2 consists of the 0.6-kb argU+ ClaI-SphI fragment of pDM1 cloned into the AccI-SphI sites of pCL1, and similarly, pCL3 consists of the 0.6-kbp argU10(Ts) fragment of pKC1 cloned into pCL1.
An AvaI-HindIII fragment of
clone 12C7 from the genomic library (20), which carries the argS gene for arginyl-tRNA synthetase, was cloned into the SalI-HindIII sites of pUC119 to generate pUA1. The argS gene on the BamHI-HindIII fragment of pUA1 was ligated to the corresponding sites of the vector pACYC184 to generate pYA1.
Site-directed mutagenesis of the argU gene. The synthetic oligomers RV (5'-CACACAGGAAACAGCTATGAC-3') and M3 (5'-CGACGTTGTAAAACGACGGCCAG-3') were designed as PCR primers for amplification of a fragment cloned in the multiple cloning site of pUC119 or pCL1. Site-directed mutagenesis of the argU gene was done by performing the following two successive PCR amplifications. The first amplification was carried out with the oligomer RV and a mutagenic oligomer as PCR primers and plasmid pCL2 as the template. The 0.3-kb fragment obtained was purified by agarose gel electrophoresis, and the second amplification was carried out with this fragment and the oligomer M3 as the primers and pCL2 as the template. Finally, the 0.6-kb fragment obtained was digested with EcoRI and HindIII and ligated into the corresponding sites of pCL1 or pBR322. Base substitutions were confirmed by DNA sequencing.
Preparation of the argU tRNA, EF-Tu, and arginyl-tRNA synthetase. The wild-type and mutant argU tRNA species were overproduced in W3110 harboring pDM1 at 37°C and in GM10 harboring pKC1 at 30°C, respectively. The tRNAs were extracted from the late-log-phase cells and were fractionated by high-performance liquid chromatography on a hydroxyapatite column (HA-1000; Tosoh) (34). Finally, the argU tRNAs were purified from the column fractions by polyacrylamide gel electrophoresis (PAGE) on a denaturing 20% polyacrylamide gel. EF-Tu was prepared from a W3110 cell extract by chromatography on a DEAE-Sephadex A-50 (pH 7.5) column (1). Arginyl-tRNA synthetase was purified from W3110 harboring pUA1 by successive chromatography steps, as described previously (30).
Arginylation assay. Arginylation of the wild-type or mutant argU tRNA (1 µM) by arginyl-tRNA synthetase (4 nM) was performed at 37°C in 18 µl of mixture A (100 mM Tris-HCl [pH 7.5], 15 mM MgCl2, 2 mM ATP, 60 µM [14C]arginine [332.1 pCi/pmol; Dupont/NEN Research Products]). Aliquots (4 µl) were withdrawn from the reaction mixture after 20 to 90 s of incubation and were immediately added to 10 µl of ice-chilled 5% trichloroacetic acid to stop the reaction. These samples were spotted onto Whatman 3MM filter disks, which were washed three times with ice-chilled 5% trichloroacetic acid and then dried to obtain radioactivity measurements with a liquid scintillation system (LSC-700; Aloka, Tokyo, Japan).
Assay of formation of a complex between arginyl-tRNA and EF-Tu-GTP. To prepare the wild-type and mutant argU tRNAs in the arginylated state, each tRNA species (6 pmol) was arginylated at 37°C for 10 min in mixture A containing 1 µM arginyl-tRNA synthetase. After phenol-chloroform extraction, the arginylated tRNA was precipitated with ethanol and dissolved in 5 µl of 2 mM sodium acetate buffer (pH 4.5). A 60-µl prereaction mixture containing 50 mM Tris-HCl (pH 7.5), 10 mM magnesium acetate, 150 mM NH4Cl, 50 mM ß-mercaptoethanol, 60 µM GTP, 0.8 mM phosphoenolpyruvate (Sigma), 2 U of pyruvate kinase (Sigma), and EF-Tu at the concentrations indicated below was incubated on ice for 25 min in order to replace the GDP molecule bound to EF-Tu by GTP. The arginylated argU tRNA (5 µl) was then added to this mixture, and preincubation was continued for another 5 min. After the preincubation, the reaction mixture was subjected to incubation at 30 or 43°C. The final concentration of the arginyl argU tRNAs was 0.092 µM, while the final concentration of EF-Tu was 0 or 0.062 µM at 30°C and 0 or 0.15 µM at 43°C. Aliquots (11.5 µl) of the reaction mixture were withdrawn at different times and then immediately spotted onto Whatman 3MM filter disks soaked with 5% trichloroacetic acid. The disks were washed with ice-chilled 5% trichloroacetic acid. The radioactivities of the disks were measured as described above for the arginylation assay. The rate constant for deacylation (k) was calculated by using the equation k = ln2 · t1/21, where t1/2 is the incubation time required for 50% of the arginyl tRNA molecules to be deacylated.
In vivo analysis of the tRNA aminoacylation levels. Strains YT319 and SF151 were each grown in Luria-Bertani medium (35) containing 0.1% glucose and 50 µg of thymine per ml at 30°C. At an optical density at 600 nm of 0.2, a portion of each culture was shifted to 43°C. Extraction of tRNA from the cell samples was carried out under acidic conditions, as described previously (46). An aliquot of each extract was used to measure the absorbance at 260 nm, and another aliquot was analyzed by PAGE in order to confirm that the ratio between the A260 and the amount of tRNA was constant for the tRNA preparations. This ratio would change if each tRNA preparation contained a different level of the contamination due to other nucleic acids. The remaining sample was subjected to acid-urea PAGE (46) to separate the aminoacylated and uncharged tRNAs. Transfer of tRNA from the gel to a Hybond-N nylon membrane (Amersham) was carried out with an electroblot apparatus (NA-1512; Nihon Eido, Tokyo, Japan), and the argU tRNA was detected by hybridization to a 32P-labeled oligodeoxyribonucleotide probe (5'-CGAACCTGCGGCCCACGAC-3') complementary to residues 39 to 57 of the tRNA. The intensities of the bands on the autoradiogram were measured with a BAS2000 bioimaging analyzer (Fuji Photo Film, Tokyo, Japan).
An aliquot of each tRNA extract was examined for its tyrosine acceptance as an internal control for the intracellular level of the argU tRNA. The 40 µM tRNA extract was aminoacylated at 37°C for 30 min with 20 µM L-[14C]tyrosine (16.9 GBq/mmol; New England Nuclear) in a 30-µl mixture containing 100 mM Tris-Cl (pH 7.6), 15 mM MgCl2, 40 mM KCl, 1 mM dithiothreitol, 4 mM ATP, and 50 nM E. coli tyrosyl-tRNA synthetase. The tyrosine concentration used was greater than the concentration of tyrosine tRNA species in the tRNA extract. Preparation of the tyrosyl-tRNA synthetase has been described previously (18). The radioactivity of the accepted tyrosine was measured as described above for the arginylation assay.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Growth of the argU10(Ts) mutants and the parental strains at 42°C
|
![]() View larger version (33K): [in a new window] |
FIG. 2. Growth of SF151 transformed with the following plasmids: vector pCL1 (a); the argU+ plasmid pCL2 (b); the argU(Ts) plasmid pCL3 (c); the argU alleles with U20, G20, and C20 (d, e, and f, respectively), each cloned in pCL1; vector pCL1 together with the ArgRS-overproducing plasmid pYA1 (g); the argU alleles with U20, G20, and C20 (h, i, and j, respectively), each together with pYA1; vector pBR322 (k); the argU+ plasmid pDM1 (l); and pBR322 carrying the argU gene with a CCT anticodon (m). Colonies transformed at 30°C were streaked on Luria-Bertani agar containing ampicillin (20 µg/ml) and thymine (50 µg/ml) (a to f), chloramphenicol (25 µg/ml) in addition to ampicillin (20 µg/ml) and thymine (50 µg/ml) (g to j), and ampicillin (50 µg/ml) and thymine (50 µg/ml) (k to m) and were then incubated for 24 h at 42°C.
|
Then we carried out complementation experiments using the argU tRNA variants with low arginine-accepting activities. Since A20 in the D loop of E. coli tRNAArg is required specifically for arginylation (23, 24), the base substitutions in this position only impair the arginine-accepting activity. None of the argU gene variants with C, G, and T at position 20 complemented the temperature sensitivity of SF151 (Fig. 2d to f). The complementing activities of these variants were recovered when E. coli arginyl-tRNA synthetase (ArgRS) was overproduced in SF151, while overproduction of ArgRS alone did not complement SF151 (Fig. 2g to j). This observation indicates that the arginylation of the argU tRNA is a prerequisite for the argU+ complementing activity.
These results unambiguously show that the argU10(Ts) phenotype is caused at the level of translation. In order to examine the possibility that any deleterious property of the mutant tRNA causes the argU10(Ts) phenotype, we analyzed the cell growth of the W3110 strains harboring pDM1 and pKC1, which overproduced the wild-type and mutant argU tRNA species, respectively. These overproducing strains exhibited similar doubling times (1.3 h), as determined on the basis of the optimal density at 600 nm of the culture, at 43°C. Since the overproduction of the mutant tRNA hardly affected the cell growth of the wild-type strain, it is unlikely that the temperature sensitivity of the argU10(Ts) mutant results from any possible deleterious property of the tRNA.
Effects of the argU10(Ts) mutation on the translational function of the argU tRNA. We prepared argU10(Ts) tRNA from the mutant cells that overproduced this mutant tRNA from a multicopy plasmid. Similarly, the wild-type argU tRNA was prepared from wild-type cells overproducing it. The affinity of the arginylated tRNA for EF-Tu-GTP was analyzed on the basis of protection from deacylation by EF-Tu-GTP (22, 32, 47). In the absence of EF-Tu-GTP, the arginylated molecules of the argU10(Ts) tRNA were deacylated at a rate similar to that of the arginylated molecules of the wild-type argU tRNA at both 30 and 43°C (Fig. 3). The rate constants for these deacylations were 2.9 x 102 and 8.7 x 102 min1 at 30 and 43°C, respectively.
![]() View larger version (28K): [in a new window] |
FIG. 3. Deacylation of the arginylated molecules of the wild-type argU tRNA ( and ) and the argU10(Ts) tRNA ( and ) in the presence ( and ) or absence ( and ) of EF-Tu at 30°C (A) and 43°C (B). Samples were withdrawn after incubation for 0, 10, 20, 30, and 40 min at 30°C and after incubation for 0, 6, 12, 20, and 30 min at 43°C. The relative amounts of arginyl-tRNA are plotted on a log scale against the incubation time.
|
On the other hand, an arginylation assay was performed with a tRNA concentration of 1 µM, because the Km for the arginylation of E. coli tRNAArg is 0.5 to 2.5 µM (21, 37, 45). Furthermore, in vitro arginylation assays showed that the arginylation rate of the argU10(Ts) tRNA was reduced to some extent at both 30 and 43°C compared with that of the wild-type argU tRNA (Fig. 4). The levels of this reduction were similar at these temperatures.
![]() View larger version (16K): [in a new window] |
FIG. 4. Arginylation of the wild-type ( ) and mutant () argU tRNA at 30°C (A) and 43°C (B). Samples were withdrawn after 20, 40, 60, and 90 s of incubation.
|
argU10(Ts) mutation significantly reduces the arginylation level and abundance of the argU10(Ts) tRNA in vivo. We then investigated the arginylation levels of the argU10(Ts) tRNA in the mutant cells. The wild-type and argU10(Ts) mutant strains (YT319 and SF151, respectively) were grown at 30°C, and a portion of each culture was shifted to 43°C. The tRNA fractions were extracted from these strains before and 60 min after this temperature shift. Strain YT319 continued to grow exponentially, while SF151 stopped growing 60 to 90 min after the shift.
Figure 5 shows the arginylation levels of the argU tRNAs in these strains before and after the temperature shift. The amount of tRNA extract analyzed in each lane was twofold larger for the analysis of the argU10(Ts) tRNA (Fig. 5B) than for the analysis of the argU tRNA (Fig. 5A), because the intracellular level of this mutant tRNA was much lower than that of the wild-type tRNA. The level of tyrosine acceptance, reflecting the intracellular level of tRNATyr, was determined for the same amount of each tRNA extract as an internal control for the cellular level of the argU tRNAs. It was found that most of the argU tRNA molecules were charged with arginine, and only 5% of them were deacylated in the YT319 cells at 30 and 43°C (Fig. 5A). The total amount of this wild-type tRNA was not affected by the temperature increase, and the level of tyrosine acceptance was constant as well.
![]() View larger version (76K): [in a new window] |
FIG. 5. argU tRNA arginylation levels in the wild-type cells (A) and mutant cells (B) before and 60 min after the temperature upshift (lanes 1 and 2, respectively). The tRNA extracts analyzed in each lane by acid-urea gel electrophoresis were 2.5- and 5-µg extracts in panels A and B, respectively. The positions of the arginylated and uncharged tRNAs on the gel are indicated by a and b, respectively. The argU tRNA was detected by hybridization to a 32P-labeled specific probe after transfer of tRNAs from the gel onto a nylon membrane. The values below the lanes are the relative levels of tyrosine acceptance for the tRNA extracts at the same concentration.
|
|
|
|---|
We created and used SF151, an argU10(Ts) mutant with strict temperature sensitivity, in order to judge the complementation by the argU tRNA variants unambiguously. Since SF151 has the dnaA rnh double mutation, it is defective in the initiation of DNA replication in the normal mode and probably circumvents this defect by starting the replication from unusual sites (19). Since the argU10(Ts) mutation inhibits DNA replication at a stage of polymerization, this defect in the normal mechanism for the replication initiation appears to enhance the temperature sensitivity of this mutant.
By using in vitro assays, the argU10(Ts) mutation was found to reduce both the arginylation efficiency and the affinity to EF-Tu-GTP to some extent. This mutation generates a mismatched base pair, A1-C72, at the terminus of the acceptor stem (2). Base pairing at this acceptor stem terminus is important in the binding of an aminoacyl-tRNA to EF-Tu-GTP (7, 38, 39). In the crystal structure of the aminoacyl-tRNA-EF-Tu-GTP ternary complex (29), EF-Tu binds to the sugar-phosphate backbone of residue 1 of the tRNA but not to the side of residue 72 (Fig. 6A). Base pairing between these residues places the aminoacylated 3' end of the tRNA in the correct position to facilitate its accommodation by EF-Tu-GTP. On the other hand, ArgRS interacts with the side of residue 72 but not with the side of residue 1 in the crystal structure of the yeast ArgRS-tRNAArg complex (4) (Fig. 6B). The mismatched base pair at these positions probably destabilizes the helical structure around residue 72 that facilitates the interaction with ArgRS. This probably also occurs with a prokaryotic ArgRS because of its structural similarity to yeast ArgRS (41). Because of these contrasting binding manners of EF-Tu-GTP and ArgRS, the stability of the acceptor stem at its terminus seems to be more crucial for the binding of EF-Tu-GTP, and this may explain our observation that the interaction between the argU10(Ts) tRNA and this factor alone exhibits temperature sensitivity.
![]() View larger version (43K): [in a new window] |
FIG. 6. Interactions of the G1-C72 base pair at the acceptor stem terminus with EF-Tu-GTP (28) (A) and yeast ArgRS (4) (B). EF-Tu and ArgRS are represented by blue and green ribbons, respectively. Nucleotide residues are represented by sticks, and the phosphate-sugar backbone is outlined by pink tubes. The amino acid residues of EF-Tu (A) and ArgRS (B) that interact with residues 1 to 2 and 71 to 72, respectively, are also represented by balls and sticks.
|
Single base substitutions confer temperature sensitivity on the amber suppressor tRNATyr (42, 43) and tRNATrp (6) from E. coli. These base substitutions, which occur in the central part of the tRNA, destabilize the tRNA structure (5, 42) and have thus been thought to make the mutant tRNAs more susceptible to RNases. The efficiencies of tryptophanylation are similar for the mutant tRNATrp and its wild-type counterpart (5). On the other hand, the argU10(Ts) tRNA has the mutation at an extremity, and the exposure of this tRNA to RNases is probably due to the defects in the arginylation and the binding to EF-Tu-GTP rather than to destabilization of the structure.
The different in vivo levels of the argU10(Ts) tRNA at 30 and 43°C explain the different extents to which the translation of AGA and AGG codons in the mutant cells is inhibited at these temperatures. The argU tRNA has a UCU anticodon, where the uridine in the first position is modified to 5-methylaminomethyluridine (34), and thus it recognizes both the AGA and AGG codons (44). The AGG codon is also translated by another minor tRNAArg species with a CCU anticodon, while this argU tRNA is the only tRNAArg species that decodes AGA. Therefore, the inhibited translation of the genes with AGA and AGG codons in the arg10(Ts) mutant is probably mainly due to inhibition of AGA translation, although it is not clear yet if the reduced argU tRNA levels affect the efficiency of AGG codon translation.
The reduced argU10(Ts) tRNA level at 30°C explains the Pin phenotype displayed by the argU10(Ts) mutant at this temperature. This phenotype is exhibited by E. coli when expression of the P2 old gene, with eight AGA or AGG codons (10), is inhibited (9). Interestingly, although the in vivo amount of the argU10(Ts) tRNA in the arginylated form is only 5% of the amount of the argU tRNA in wild-type cells, the expression of the E. coli genes essential for cell growth hardly seems to be impaired at this temperature.
A G1-to-A1 transition occurs in the tRNATyr and tRNAGly mutants of E. coli and Salmonella enterica serovar Typhimurium, respectively. The mutant tRNATyr can be charged with glutamine (43), because a weak base pair, including a mismatched base pair, and U35, which is also present in tRNATyr, are recognized by glutaminyl-tRNA synthetase (33). The mutant tRNAGly promotes frameshifting, and the reduced affinities for EF-Tu-GTP and/or certain ribosomal components may underlie this phenomenon (31). Although the possibility of either mischarging or frameshifting was not investigated for the argU10(Ts) tRNA, it is unlikely that a deleterious property conferred by the argU10(Ts) mutation causes the temperature sensitivity, because the overproduction of the argU10(Ts) tRNA hardly affects cell growth.
In conclusion, the functional defects of the argU10(Ts) tRNA reduce the cellular abundance of this tRNA to different extents at various temperatures, and this is the molecular basis for the pleiotropic effects of the argU10(Ts) mutation.
This work was supported by the RIKEN Structural Genomics/Proteomics Initiative, National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan.
Present address: Osaka Bioscience Institute, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan. ![]()
|
|
|---|
interference. J. Virol. 48:616-626.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»